Categories: Healthcare

Mycoplasma Detection Systems Market

The Mycoplasma Testing Global Market Report 2023 by The Business Research Company, provides mycoplasma testing market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Mycoplasma Testing Market:

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

According to The Business Research Company’s Mycoplasma Testing Global Market Report 2023, the market size is expected to grow from$0.81 billion in 2022 to $0.92 billion in 2023 at a compound annual growth rate (CAGR) of 13.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the mycoplasma testing is expected to grow to $1.47 billion in 2027 at a CAGR of 12.5%.

The prevalence of mycoplasma pneumonia co-infection among patients with COVID-19 is expected to boost the market for mycoplasma testing in the forecast period. The presence of co-infection of M. pneumonia increases the need to test patients with COVID-19, increasing demand for routine diagnostic tests for respiratory pathogens like M. pneumonia. The coinfections in COVID-19 cases has a significant probability of them being caused by Mycoplasma pneuminiae.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=4103&type=smp

The mycoplasma testing market is segmented:

1) By Product: Instruments, Assay, Kits, and Reagents

2) By Technology: PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies

3) By Application: Cell line Testing, Virus Testing, End- of- Production Cell Testing

4) By End User: Pharmaceutical & Biotechnology Companies, Cell Banks & Laboratories, Contract Research Organizations, Academic Research Institutes

Major players operating in the market are undertaking various strategic investments such as the launch of innovative products, research and development advancements, and technological innovations, which are gaining significant popularity in the mycoplasma testing market. Companies are introducing new innovative products to meet the requirements of end-users and expand the consumer base to survive in the competitive business environment. For instance, in July 2020, bioMérieux, a France-based biotechnology company introduced Bio Fire Mycoplasma, an advanced test used for bio-therapeutics including hormones, antibodies, gene, and cell therapies for mycoplasma detection in pharmaceutical products.

The mycoplasma testing market report table of contents includes: